SCHIZOPHRENIFORM DISORDERS
Clinical trials for SCHIZOPHRENIFORM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new SCHIZOPHRENIFORM DISORDERS trials appear
Sign up with your email to follow new studies for SCHIZOPHRENIFORM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Simple text messages aim to bridge critical gap in mental health care for youth
Disease control CompletedThis study tested whether simple text messages could help young people with psychosis get from the emergency room to their first scheduled mental health appointment. Researchers enrolled 186 young adults (ages 16-29) who were referred from an emergency department to a specialized…
Matched conditions: SCHIZOPHRENIFORM DISORDERS
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Apr 04, 2026 01:35 UTC
-
New program aims to transform care for youth with psychosis
Disease control CompletedThis study tested a program called NAVIGATE, which provides coordinated, manual-based care for young people (ages 14-35) experiencing their first episode of psychosis. The goal was to see if implementing this structured program in existing Ontario clinics could improve the qualit…
Matched conditions: SCHIZOPHRENIFORM DISORDERS
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Can video calls keep people with psychosis out of the hospital?
Disease control CompletedThis study tested whether delivering specialized early psychosis care via video calls (telehealth) works as well as standard in-clinic visits. It involved 74 young adults (ages 16-35) with recent-onset psychotic disorders. Over 12 months, researchers compared how often participan…
Matched conditions: SCHIZOPHRENIFORM DISORDERS
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Researchers check for withdrawal from agitation drug
Symptom relief CompletedThis study looked at what happens when people stop taking the medication Igalmi after using it for a week to treat severe agitation. It involved 29 adults with schizophrenia or bipolar disorder who took the drug as needed for agitation over 7 days, then were monitored for 3 days …
Matched conditions: SCHIZOPHRENIFORM DISORDERS
Phase: PHASE4 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Apr 03, 2026 14:41 UTC
-
New At-Home calming treatment tested for mental health crises
Symptom relief CompletedThis study tested a medication called BXCL501 to see if it could safely and effectively calm episodes of agitation when used at home by adults with schizophrenia or bipolar disorder. In the second part of the trial, 452 participants used the medication as needed over 12 weeks at …
Matched conditions: SCHIZOPHRENIFORM DISORDERS
Phase: PHASE3 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test remote brain games to help young adults with psychosis
Knowledge-focused CompletedThis study tested whether two types of visual brain training could improve thinking skills in young adults with early psychosis. Researchers enrolled 152 people aged 18-30, including those with conditions like schizophrenia and those without any psychiatric diagnosis. The study w…
Matched conditions: SCHIZOPHRENIFORM DISORDERS
Phase: EARLY_PHASE1 • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC